|Bid||61.63 x 3000|
|Ask||62.02 x 1000|
|Day's Range||61.61 - 63.58|
|52 Week Range||57.17 - 74.12|
|Beta (5Y Monthly)||0.33|
|PE Ratio (TTM)||18.87|
|Earnings Date||Oct 26, 2022 - Oct 31, 2022|
|Forward Dividend & Yield||2.92 (4.73%)|
|Ex-Dividend Date||Sept 14, 2022|
|1y Target Est||71.07|
The healthcare industry is a great place to start. Let's examine two biotechs that seem to be able to do that: Gilead Sciences (NASDAQ: GILD) and CRISPR Therapeutics (NASDAQ: CRSP). Gilead Sciences is a leader in the market for HIV drugs although the company has recently faced some headwinds in this space.
A look at the shareholders of Gilead Sciences, Inc. ( NASDAQ:GILD ) can tell us which group is most powerful. And the...
Kelly was getting ready to leave on a trip to celebrate her 25th wedding anniversary when she started experiencing pain in her abdomen and discovered a lump on her neck. When the pain progressed to the point where it got worse when she laid down, she asked her husband, an emergency room doctor, what he thought.